Ruxolitinib phosphate

FDA Drug Profile

Drug Details

Generic Name
Ruxolitinib phosphate
Brand Names
N/A
Application Number
Sponsor
American Pacific Corporation
NDC Codes
4
Dosage Forms
POWDER
Routes
N/A
Active Ingredients
RUXOLITINIB PHOSPHATE

Indications and Usage

1 INDICATIONS AND USAGE LEQSELVI™ is indicated for the treatment of adult patients with severe alopecia areata. Limitations of Use LEQSELVI is not recommended for use in combination with other JAK inhibitors, biologic immunomodulators, cyclosporine, or other potent immunosuppressants. LEQSELVI is a Janus kinase (JAK) inhibitor indicated for the treatment of adults with severe alopecia areata. ( 1 ) Limitations of Use: LEQSELVI is not recommended for use in combination with other JAK inhibitors, biologic immunomodulators, cyclosporine or other potent immunosuppressants. ( 1 )